IMP is a basic biomedical research institute, largely sponsored by Boehringer Ingelheim.

With approximately 250 international staff, the IMP is committed to scientific discovery of fundamental molecular and cellular mechanisms underlying complex biological phenomena. Key research areas are cell and molecular biology, neurobiology, disease mechanisms and computational biology.

IMP – Research Institute of Molecular Pathology GmbH
Campus-Vienna-Biocenter 1
1030 Vienna
Building: IMP – Map

+43 (0) 1 797 30